Shopping Cart
- Remove All
- Your shopping cart is currently empty
CLR-131, a protein kinase B (PKB) inhibitor, is used potentially for the treatment of non small cell lung cancer, solid tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.871 € | 8-10 weeks | |
50 mg | 2.451 € | 8-10 weeks | |
100 mg | 3.230 € | 8-10 weeks |
Description | CLR-131, a protein kinase B (PKB) inhibitor, is used potentially for the treatment of non small cell lung cancer, solid tumors. |
Alias | I-131-CLR-1404, I-131CLR1404, I 131CLR1404, I 131 CLR 1404, 131I-NM-404 |
Molecular Weight | 641.62 |
Formula | C29H53INO4P |
Cas No. | 873438-88-1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.